2017
DOI: 10.1136/bmjspcare-2017-001330
|View full text |Cite
|
Sign up to set email alerts
|

Development of tools to facilitate palliative and supportive care referral for patients with idiopathic pulmonary fibrosis

Abstract: Palliative care services are underused in ILD and a supportive care decision aid can prompt consideration of palliative and supportive care needs.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
30
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 24 publications
(30 citation statements)
references
References 18 publications
0
30
0
Order By: Relevance
“…Characteristics of the existing studies are summarized in Table . Countries where the studies were conducted were the UK, (Bajwah et al., , ; Duck et al., ; Sampson, Gill, Harrison, Nelson, & Byrne, ; Sharp et al., ), the USA (Liang et al., ; Lindell, Kavalieratos, Gibson, Tycon, & Rosenzweig, ; Lindell et al., , ; Rush, Berger, & Celi, ; Swetz, Carey, & Bundrick, ), Canada (Kalluri, Claveria, Haggag, & Richman‐Eisenstat, ; Kalluri et al., , ; Periyakoil, Skultety, & Sheikh, ), Japan (Arita et al., ), Finland (Rajala et al., ), Denmark (Overgaard et al., ) and Sweden (Ahmadi et al., ). The combined 19 studies comprised 1708 patients and 74 care partners.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…Characteristics of the existing studies are summarized in Table . Countries where the studies were conducted were the UK, (Bajwah et al., , ; Duck et al., ; Sampson, Gill, Harrison, Nelson, & Byrne, ; Sharp et al., ), the USA (Liang et al., ; Lindell, Kavalieratos, Gibson, Tycon, & Rosenzweig, ; Lindell et al., , ; Rush, Berger, & Celi, ; Swetz, Carey, & Bundrick, ), Canada (Kalluri, Claveria, Haggag, & Richman‐Eisenstat, ; Kalluri et al., , ; Periyakoil, Skultety, & Sheikh, ), Japan (Arita et al., ), Finland (Rajala et al., ), Denmark (Overgaard et al., ) and Sweden (Ahmadi et al., ). The combined 19 studies comprised 1708 patients and 74 care partners.…”
Section: Resultsmentioning
confidence: 99%
“…The age range was between 52 and 78 years. The environments where patients received palliative care were home care (Arita et al., ; Bajwah et al., ; Duck et al., ; Kalluri et al., ; Lindell et al., , ; Overgaard et al., ; Periyakoil et al., ; Rajala et al., ; Sampson et al., ; Sharp et al., ; Swetz et al., ), inpatient ward (Arita et al., ; Rush et al., ), intensive care unit (Rajala et al., ), hospice care (Liang et al., ; Lindell et al., ) and outpatient respiratory centres (Ahmadi et al., ; Bajwah et al., ).…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Sensitive advanced care planning, and timely patient-centred end of life care with much-needed counselling with patients and their caregivers, as well as appropriate pharmacotherapy to alleviate emotional and physical suffering, must be an integrated part of routine care of patients with PF-ILD. [20] Beyond idiopathic pulmonary fibrosis diagnosis: multidisciplinary care with an early integrated palliative approach is associated with a decrease in acute care utilization and hospital deaths LINDELL et al [9] Randomised clinical trial of an early palliative care intervention (SUPPORT) for patients with idiopathic pulmonary fibrosis (IPF) and their caregivers: protocol and key design considerations RUSH et al [21] Access to palliative care for patients undergoing mechanical ventilation with idiopathic pulmonary fibrosis in the United States SHARP et al [22] Development of tools to facilitate palliative and supportive care referral for patients with idiopathic pulmonary fibrosis https://doi.org/10.1183/13993003.02086-2018 Table 1 lists some of the current palliative care studies that are underway. While we are not aware of all clinical studies that are ongoing and/or have been completed, it is hoped that there are and/or will be more clinical studies addressing palliative care in this cohort of patients and provide evidence to enhance further understanding and management of PF-ILD and improve outcomes that are meaningful to these patients.…”
Section: @Erspublicationsmentioning
confidence: 99%